SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027695
Filing Date
2021-05-14
Accepted
2021-05-13 18:11:13
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eldn-10q_20210331.htm 10-Q 1498047
2 EX-31.1 eldn-ex311_7.htm EX-31.1 11382
3 EX-31.2 eldn-ex312_6.htm EX-31.2 11414
4 EX-32.1 eldn-ex321_8.htm EX-32.1 7505
5 EX-32.2 eldn-ex322_9.htm EX-32.2 7781
  Complete submission text file 0001564590-21-027695.txt   4975598

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eldn-20210331.xml EX-101.INS 841632
7 XBRL TAXONOMY EXTENSION SCHEMA eldn-20210331.xsd EX-101.SCH 48907
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eldn-20210331_cal.xml EX-101.CAL 41767
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eldn-20210331_def.xml EX-101.DEF 166803
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eldn-20210331_lab.xml EX-101.LAB 331274
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eldn-20210331_pre.xml EX-101.PRE 265916
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 21921166
SIC: 2834 Pharmaceutical Preparations